Cyclophosphamide, Methotrexate, and 5-Fluorouracil (CMF)-Induced Ocular Toxicity
作者:
LoprinziCharles L.,
LoveRichard R.,
GarrityJames A.,
AmesMatthew M.,
期刊:
Cancer Investigation
(Taylor Available online 1990)
卷期:
Volume 8,
issue 5
页码: 459-465
ISSN:0735-7907
年代: 1990
DOI:10.3109/07357909009012068
出版商: Taylor&Francis
数据来源: Taylor
摘要:
AbstractOcular toxicity is a common, but poorly understood, sequela from CMF chemotherapy. We investigated this toxicity in patients receiving CMF therapy. Detailed interviews in 210 patients revealed that new, unpleasant ocular symptoms developed in 42% of patients receiving CMF, in 39% of subjects receiving other regimens containing 5-fluorouracil (5-FU), and only in 18% of subjects receiving a variety of chemotherapy regimens not containing 5-FU. CMF-associated ocular symptoms usually consisted of mild to marked tearing, ocular pruritis, and/or burning. These toxicities usually began 11–17 days after starting a cycle of CMF and lasted for 10–15 days. 5-FU was detected in the tears of 12 tested patients within several minutes after intravenous 5-FU (peak concentrations as high as 60µg/ml). 5-FU tear concentrations did not correlate with the presence or absence of ocular toxicity. There is no established antidote for this toxicity although some patients have reported subjective benefit from cryotherapy, applied around the period of 5-FU injections, or cromolyn sodium eye drops.
点击下载:
PDF (534KB)
返 回